IP Library Granted Patent US 8,292,822
Granted Patent B2
US 8,292,822 · App. 10/839,112 · Granted Oct 23, 2012

Biopsy localization method and device

Assignee: Devicor Medical Products, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,292,822
App. No.
10/839,112
Granted
Oct 23, 2012
Kind
B2
Abstract

A biopsy localization device made according to the invention includes a bioresorbable element, such as a cellulose. The bioresorbable element preferably carries a radiopaque marker. The bioresorbable element preferably swells to fill the biopsied open region. The bioresorbable element and radiopaque marker permit the biopsy site to be relocated by various techniques, including mammography and ultrasound. In addition, the bioresorbable element can be used as a therapeutic tool for treatment of the diseased lesion and for hemostasis.

Claims (11)

1. A method for marking a biopsy cavity comprising the steps of:

providing a substantially dehydrated bioresorbable body having a radiopaque marker carried by the bioresorbable body, said bioresorbable body comprising cellulose;

removing a biopsy specimen from the breast of a patient, thereby creating a biopsy site;

inserting the bioresorbable body into the biopsy site to mark the location of the biopsy site, wherein the bioresorbable body after insertion contacts body fluid and swells to substantially fill the biopsy site.

2. The method of claim 1 , further comprising the step of relocating the biopsy site by detecting the radiopaque marker.

3. The method of claim 1 , wherein the bioresorbable body comprises a single bioresorbable body.

4. The method of claim 1 , wherein the radiopaque marker is contained within the bioresorbable body.

5. The method of claim 1 , wherein the radiopaque marker is detected by mammography.

6. The method of claim 1 , wherein the radiopaque marker is detected by ultrasound.

7. The method of claim 1 , wherein the bioresorbable body swells about 100 to 300 percent in a post delivery state of the bioresorbable body relative to a pre-delivery state of the bioresorbable body.

8. The method of claim 1 , wherein the bioresorbable body is softer in a post delivery state of the bioresorbable body than in a pre-delivery state of the bioresorbable body.

Assignments (1)
SECURITY AGREEMENT Recorded Jul 13, 2010
From: ARTEMIS MEDICAL, INC.
To: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
Reel/Frame 024672/0377 →
Continuity (8)
Continuation 10027157 · Dec 20, 2001
Continuation 09900801 · Jul 6, 2001
Continuation 09336360 · Jun 18, 1999
Provisional Application 60090243 · Jun 22, 1998
Provisional Application 60092734 · Jul 14, 1998
Provisional Application 60114863 · Jan 6, 1999
Provisional Application 60117421 · Jan 27, 1999
Related Publication 20040210160A1 · Oct 21, 2004